The estimated Net Worth of Randall Rupp is at least $5.25 millió dollars as of 13 April 2007. Randall Rupp owns over 31,250 units of Regeneron Pharmaceuticals stock worth over $4,721,037 and over the last 21 years Randall sold REGN stock worth over $533,055.
Randall has made over 9 trades of the Regeneron Pharmaceuticals stock since 2003, according to the Form 4 filled with the SEC. Most recently Randall exercised 31,250 units of REGN stock worth $340,313 on 13 April 2007.
The largest trade Randall's ever made was exercising 143,750 units of Regeneron Pharmaceuticals stock on 31 October 2006 worth over $1,335,438. On average, Randall trades about 19,551 units every 93 days since 2003. As of 13 April 2007 Randall still owns at least 4,136 units of Regeneron Pharmaceuticals stock.
You can see the complete history of Randall Rupp stock trades at the bottom of the page.
Over the last 22 years, insiders at Regeneron Pharmaceuticals have traded over $13,084,686,326 worth of Regeneron Pharmaceuticals stock and bought 8,562,481 units worth $2,539,854,760 . The most active insiders traders include Sanofi, Pharma Ag Novartis és Leonard S Schleifer. On average, Regeneron Pharmaceuticals executives and independent directors trade stock every 8 days with the average trade being worth of $47,694,347. The most recent stock trade was executed by Marion Mc Court on 3 September 2024, trading 1,000 units of REGN stock currently worth $381,400.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Regeneron Pharmaceuticals executives and other stock owners filed with the SEC include: